To ensure diversity and independence of Board members, directors shall be elected pursuant to the candidates nomination system in accordance with TSH Biopharm’s “Articles of Incorporation”, “Procedures for Election of Directors” and “Corporate Governance Best-Practice Principles”.
The Company's Board of Directors is currently set up with seven directors, three of which are independent directors.
The term of office of the current Board of Directors is from May 29, 2020 to May 28, 2023.
Current Position(s): Chairman, TTY Biopharm Company Limited
Ph.D., Economics, University of Illinois at Urbana-Champaign, USA
Director, TSH Biopharm Corporation Ltd.
PharmD, University of the Pacific Thomas J Long School of Pharmacy MBA, University of the Pacific Eberhardt School of Business
Remuneration Committee Member, Pharma Engine
Bachelor’s Degree, Economics, Tung Hai University MA in Economics, University of Memphis
Chairman and CEO, IROC Co., Ltd.
Remuneration Committee Member, TSH Biopharm Corporation Ltd.
Independent Director, CCP Contact Probes Co., Ltd.
Independent Director, Radium Construction Co., Ltd.
Independent Director, Chant Sincere Co., Ltd.
International MBA, University of St. Thomas, Minnesota State, USA
Partner, Moores Rowland CPAs
Independent Director, Pharma Engine
Bachelor’s Degree in Accounting, Soochow University
Chairman, Yuanta Securities (Hong Kong) Co., Ltd.
Director, Yuanta Hong Kong Holdings (Cayman) Ltd.
Director, Yuanta Investment Management (Cayman)
Director, Yuanta Asia Investment (Hong Kong) Limited
Authorized Representative, Yuanta Securities Vietnam Limited Company
Master’s Degree in Accounting, National Changhua University of Education
Independent Director, Welgene Biotech Co., Ltd.
Chairman, FAITH LEAPER, CO.
MBA, Columbia Business School, USA
Bachelor’s Degree in Biology, National Taiwan Normal University
According to Article 20 of the Company’s “Corporate Governance Best-Practice Principles” below:
TSH Biopharm’s 5th session of Board of Directors is set up with seven directors, three of which are independent directors. According to the Company’s policy on diversity, the members are experts of industrial, academic and medical areas, covering finance, accounting and other professional fields. They are equipped with the knowledge, skills and competencies to perform their duties,
Please refer to the following table for the diversity of the Board members:
|Core Items||Nationality||Gender||Operation management||Leadership decision||Industry knowledge||Finance Accounting||Law|
|Independent director||Wang, Chih-Li||Taiwan||Male||V||V|
|Independent director||Wang, Yi-Min||Taiwan||Male||V||V||V|
|Independent director||Chen, Rwei-Syun||Taiwan||Female||V||V|
The average age of the Board of Directors is 62.29. One director is 34 years old, one director is aged between 56-60, two directors are aged between 61-65, one director is aged between 66-69, one director is aged between 70-75 and one between 76-80 years of age.
Concurrently an employee of the Company both accounts for 0% of directors and independent directors.
Female director accounts for 14.2% of Board members.
All three independent director tenure average below 3 years.
Besides chairman and general manager, the Company also has directors for different functions. Due to sustainable development, the Company cultivates key talents for important management in various fields.
The Company has established the Talent Development Program since 2012 in order to cultivate a leader with three professional functions, including sales and marketing, research and development and management. Furthermore, the Company is constantly cultivating international market development staff and middle-level sales and marketing managers by Leadership Enhancement Action Plan. Leadership Enhancement Action Plan has been initiated since 2020.